From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the french intergroup (IFCT) and the groupe d’Oncologie de langue française
Auteurs / Authors: S. Couraud, A. Cortot, L. Greillier, V. Gounant, B. Mennecier, N. Girard, B. Besse, L. Brouchet, O. Castelnau, P. Frappé, G. Ferretti, L. Guittet, A. Khalil, P. Lefebure, F. Laurent, S. Liebart, O. Molinier, E. Quoix, M-P. Revel, B. Stach, P-J. Souquet, P. Thomas, J. Trédaniel, E. Lemarié, G. Zalcman, F. Barlesi, B. Milleron on behalf of the French lung cancer screening statement taskforce.
Journal / Conference: Annals of Oncology
Année / Year: 2013
PMID: 23136229
Lien vers la publication: https://www.ncbi.nlm.nih.gov/pubmed/23136229